Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Our Company

Getting the Word Out

Today's Top Reads Close

So today – at long last -- the distribution of important medical information is fully entering the electronic age.

Earlier today, the Health Care Notification Network, or HCNN, which provides electronic alerts to US physicians, was launched. You can find out more about it here and here, but to really grasp the significance of HCNN, you have to keep in mind how US doctors currently hear about important safety information. Put quite simply, when this info needs to get out, for the most part it is printed and distributed via the postal service. However, through HCNN these alerts will be distributed via e-mail --- which will surely be a more effective and efficient way to get the news out. (You can sign up for these alerts here...)

While news about HCNN is spreading, the role Johnson & Johnson played in all of this is not widely known.

My involvement with this project brought me in close contact with Christine Cote – who, while working for our Janssen Pharmaceutica business – came up with the idea of distributing these alerts electronically. Rather than me telling her tale, I thought you might be interested in Christine's story in her own words...

Six years ago, when I was heading up medical affairs for our Janssen business, one weekend we had to put out an alert about the pain medicine Duragesic. In doing this, I was very surprised to learn how difficult it was to get the notification printed, stuffed in envelopes and out the door – a process further complicated by a snowstorm that blanketed the North East and shut down mail delivery.

If these alerts are really about ensuring patient safety – it occurred to me that they should be distributed much more quickly and efficiently - and why on earth are we not using an email system with receipts. Depending on the mail service is far from ideal. Delays, old addresses, lost letters and all that – plus the difficulties of ensuring that physicians have received the notifications is really not satisfactory.

Relying on a paper-driven system seemed strangely anachronistic given how most businesses had been transformed by e-mail and different online tools almost a decade earlier. With this in mind, I worked very closely with the IT experts at Johnson & Johnson's specialist group called eJNJ, who then set to work to determine how to make electronic notification a reality.

They couldn't do it on their own – and so they turned to Medem who then led the charge. Under the leadership of eJNJ, our Regulatory Group, Safety Group, Government Affairs and Communication Group worked with Medem to provide more detailed insight and specifications that would be required for a successful Safety Alert Notification System including meeting with the FDA. The result, after years of hard work by Medem and an unprecedented collaboration with the regulatory authorities, patient advocacy groups, industry and technology companies, is the HCNN. I am now working with Adrian Thomas, our Chief Safety Officer, and each operating company at Johnson & Johnson, to map out our transition from the paper based alert system to the HCNN electronic system. I am very proud that we have been able to take the lead on this initiative to substantially optimize the Product Patient Alerting System.

The work doesn't end here. HCNN still has to get other companies to join in and there are hundreds of thousands of physicians who have to join the network. For some time, alerting physicians will include using both paper and electronic methods. But creating the network was a big hurdle to overcome. I suspect that once people see what this may mean for patient safety, I'm sure they will join in. And indeed, tens of thousands of physicians have already signed onto the network

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.